Literature DB >> 30912199

Predictors of low urinary quality of life in spinal cord injury patients on clean intermittent catheterization.

Iryna M Crescenze1, Jeremy B Myers2, Sara M Lenherr2, Sean P Elliott3, Blayne Welk4, Diana O'Dell Mph1, Yongmei Qin1, Angela P Presson2, John T Stoffel1.   

Abstract

OBJECTIVE: Clean intermittent catheterization (CIC) is a preferred method of bladder management for many patients with spinal cord injury (SCI), but long-term adherence is low. The aim of this study is to identify factors associated with low urinary quality of life (QoL) in SCI adults performing CIC.
METHODS: Over 1.5 years, 1479 adults with SCI were prospectively enrolled through the Neurogenic Bladder Research Group registry, and 753 on CIC with no prior surgeries were included. Injury characteristics, complications, hand function, and Neurogenic Bladder Symptom Score (NBSS) were analyzed. The NBSS QoL question (overall satisfaction with urinary function) was dichotomized to generate comparative groups (dissatisfied vs neutral/satisfied).
RESULTS: The cohort was 32.9% female with a median age of 43.2 (18-86) years, time since the injury of 9.8 (0-48.2) years, and 69.0% had an injury at T1 or below. Overall 36.1% were dissatisfied with urinary QoL. On multivariable analysis, female gender (odds ratio [OR], 1.63; 95% confidence interval [CI], 1.15-2.31; P = 0.016), earlier injury (OR, 0.95 per year; 95% CI, 0.93-0.97; P < 0.001), ≥4 urinary tract infections (UTIs) per year (OR, 2.36; 95% CI, 1.47-3.81; P = 0.001), and severe bowel dysfunction (OR, 1.42; 95% CI, 1.02-1.98; P = 0.035) predicted dissatisfaction. Level of injury, fine motor hand function, and caregiver dependence for CIC were not associated with dissatisfaction.
CONCLUSIONS: In a mature SCI cohort, physical disability does not predict dissatisfaction with urinary QoL but severe bowel dysfunction and recurrent UTIs have a significant negative impact. With time the rates of dissatisfaction decline but women continue to be highly dissatisfied on CIC and may benefit from early intervention to minimize the burden of CIC on urinary QoL.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  clean intermittent catheterization; neurogenic bladder; patient-reported outcomes; spinal cord injury

Mesh:

Year:  2019        PMID: 30912199     DOI: 10.1002/nau.23983

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  5 in total

1.  Time-Related Changes in Patient Reported Bladder Symptoms and Satisfaction after Spinal Cord Injury.

Authors:  Odinachi Moghalu; John T Stoffel; Sean P Elliott; Blayne Welk; Chong Zhang; Angela Presson; Jeremy Myers
Journal:  J Urol       Date:  2021-09-22       Impact factor: 7.450

2.  Recovering Voiding and Sex Function in a Patient with Chronic Complete Spinal Cord Injury by Olfactory Ensheathing Cell Transplantation.

Authors:  Di Chen; Haitao Xi; Ke Tan; Hongyun Huang
Journal:  Case Rep Neurol Med       Date:  2022-07-06

3.  A Primary Care Provider's Guide to Clinical Needs of Women With Spinal Cord Injury.

Authors:  Chloe Slocum; Molly Halloran; Cody Unser
Journal:  Top Spinal Cord Inj Rehabil       Date:  2020

4.  UTI assessment tool for intermittent catheter users: a way to include user perspectives and enhance quality of UTI management.

Authors:  S V Lauridsen; M A Averbeck; A Krassioukov; R Vaabengaard; S Athanasiadou
Journal:  BMC Nurs       Date:  2022-10-06

5.  TASCI-transcutaneous tibial nerve stimulation in patients with acute spinal cord injury to prevent neurogenic detrusor overactivity: protocol for a nationwide, randomised, sham-controlled, double-blind clinical trial.

Authors:  Veronika Birkhäuser; Martina D Liechti; Collene E Anderson; Lucas M Bachmann; Sarah Baumann; Michael Baumberger; Lori A Birder; Sander M Botter; Silvan Büeler; Célia D Cruz; Gergely David; Patrick Freund; Susanne Friedl; Oliver Gross; Margret Hund-Georgiadis; Knut Husmann; Xavier Jordan; Miriam Koschorke; Lorenz Leitner; Eugenia Luca; Ulrich Mehnert; Sandra Möhr; Freschta Mohammadzada; Katia Monastyrskaya; Nikolai Pfender; Daniel Pohl; Helen Sadri; Andrea M Sartori; Martin Schubert; Kai Sprengel; Stephanie A Stalder; Jivko Stoyanov; Cornelia Stress; Aurora Tatu; Cécile Tawadros; Stéphanie van der Lely; Jens Wöllner; Veronika Zubler; Armin Curt; Jürgen Pannek; Martin W G Brinkhof; Thomas M Kessler
Journal:  BMJ Open       Date:  2020-08-13       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.